PFO
PGEN icon

Pathstone Family Office’s Precigen PGEN Stock Holding History

Pathstone Family Office’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38,434
Closed -$44.2K – 1684
2023
Q2 		$44.2K Hold
38,434
– – ﹤0.01% 1216
2023
Q1 		$40.7K Sell
38,434
-38,434
-50% -$55.4K ﹤0.01% 1165
2022
Q4 		$117K Buy
+76,868
New +$132K ﹤0.01% 1430

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pathstone Family Office's PGEN Position: Q3 2023 in Review

Pathstone Family Office sold out of Precigen (PGEN) in Q3 2023, closing a stake of 38,434 shares — an estimated $44.2K sold.

Pathstone Family Office first reported a position in PGEN in Q4 2022 and held it in 3 quarters. The position peaked at $117K in Q4 2022. 138 funds tracked by Wall St. Rank hold PGEN as of Q3 2023.

  • Pathstone Family Office reported no remaining Precigen position as of Q3 2023 after selling out during the quarter.
  • Pathstone Family Office sold 38,434 Precigen shares in Q3 2023, an estimated $44.2K.
  • Pathstone Family Office first reported a position in Precigen in Q4 2022 and held it in 3 quarters.
  • Pathstone Family Office's Precigen position peaked at $117K in Q4 2022.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.